Literature DB >> 12186621

Tuberculosis therapy and telemedicine.

James DeMaio1, Dian Sharma.   

Abstract

Directly observed therapy (DOT) ensures patient adherence through the administration of medications by trained health department personnel. This approach has been widely adopted in tuberculosis care. Unfortunately, DOT programs require a substantial commitment of scarce public health funds and personnel time. The application of telemedicine to DOT promises considerable cost and time savings.

Entities:  

Mesh:

Year:  2002        PMID: 12186621     DOI: 10.1517/14656566.3.9.1283

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  5 in total

Review 1.  The Current and Future Use of Telemedicine in Infectious Diseases Practice.

Authors:  Caitlin E Coombes; Megan E Gregory
Journal:  Curr Infect Dis Rep       Date:  2019-10-19       Impact factor: 3.725

2.  Combined effect of pill refilling and self-medication reminder system on patients' adherence to tuberculosis treatment during continuation phase in Northwest Ethiopia: a study protocol for randomised controlled trial.

Authors:  Kassahun Dessie Gashu; Kassahun Alemu Gelaye; Richard Lester; Binyam Tilahun
Journal:  BMJ Health Care Inform       Date:  2019-08

3.  Exposure to mass media family planning messages and associated factors among youth men in Ethiopia.

Authors:  Zinie Abita; Desalegn Girma
Journal:  Heliyon       Date:  2022-09-06

Review 4.  Telemedicine in Pediatric Infectious Diseases.

Authors:  Marco Pappalardo; Umberto Fanelli; Vincenzo Chiné; Cosimo Neglia; Andrea Gramegna; Alberto Argentiero; Susanna Esposito
Journal:  Children (Basel)       Date:  2021-03-28

5.  Effect of a phone reminder system on patient-centered tuberculosis treatment adherence among adults in Northwest Ethiopia: a randomised controlled trial.

Authors:  Kassahun Dessie Gashu; Kassahun Alemu Gelaye; Richard Lester; Binyam Tilahun
Journal:  BMJ Health Care Inform       Date:  2021-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.